Global Zika Virus Therapeutics Market 2024-2028
The zika virus therapeutics market is forecasted to grow by USD 4174.3 mn during 2023-2028, accelerating at a CAGR of 4.5% during the forecast period. The report on the zika virus therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by availability of serology kit for qualitative diagnosis of zika virus infection, high incidence rate of infection, and disease burden of zika virus infection and associated comorbidities.
Technavio's zika virus therapeutics market is segmented as below:
By Product
- Acetaminophen
- Other NSAIDs
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the increasing efforts by government and private organizations to facilitate vaccine development as one of the prime reasons driving the zika virus therapeutics market growth during the next few years. Also, classification of zika virus infection as a public health emergency and novel approach for vaccine development will lead to sizable demand in the market.
The report on the zika virus therapeutics market covers the following areas:
- Zika virus therapeutics market sizing
- Zika virus therapeutics market forecast
- Zika virus therapeutics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading zika virus therapeutics market vendors that include Aurobindo Pharma Ltd., Bharat Biotech Ltd., BioVaxys Technology Corp., Emergent BioSolutions Inc., GeoVax Labs Inc., Granules India Ltd., Inovio Pharmaceuticals Inc., Johnson and Johnson Services Inc., Merck and Co. Inc., Moderna Inc., Perrigo Co. Plc, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., and Valneva SE. Also, the zika virus therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.